Appartement De Nouvelle Construction Via Aurelia Da 306

DOMUS AURELIAE - In the splendid Aurelio district, on Via Aurelia at the height of Ergife, we offer for sale an apartment in a building under construction with delivery in December 2027. The building is arranged over seven floors above ground plus a garage and cellars on the S1 floor. The project involves the creation of a building where the dialogue between materials and geometries generates a strong architectural character. Isotex construction system that guarantees solidity, thermal and acoustic insulation, and seismic resistance, thus high energy performance buildings. The apartment, located on the 3rd floor, consists of a living room with dining area, open kitchen with large openings towards the outside that favor natural light and ventilation, a master bedroom with generous spaces, a second versatile and functional room, perfect as a children’s bedroom or as a private study for smart working, and two bathrooms. Completing the property is a large balcony of about 55 sqm. Parquet flooring for interiors or porcelain stoneware, home automation system, video intercom, integrated central vacuum system, private gym. Possibility of purchasing a garage and cellar. Domus Aureliae: an idea of an evolved and contemporary home, where every detail is designed to offer well-being, functionality, and authentic comfort. For information, contact Rezza Real Estate Spa Piazza di Spagna 32 Rome Tel. 06 474951. The confidentiality of information requires professional seriousness in behavior, so any details will be communicated only to direct interested parties by appointment. There is no intention to collaborate with intermediaries or representatives of unknown third parties. The information provided has no contractual content. The dimensions in terms of volumes and commercial square meters are purely indicative. The data regarding commercial information related to the published listings comes directly from the real estate agency from the respective mediation assignments. Rezza declines any responsibility for the presence of any erroneous indications.